Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN84194243
ISRCTN84194243
Completed
Not Applicable

Development of effective primary care treatment of severe sleep disorders in children with a learning disability; a randomised controlled trial

HS R&D Regional Programme Register - Department of Health (UK)0 sites66 target enrollmentJanuary 23, 2004
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSleep disorderslearning disabilityMental and Behavioural DisordersNonorganic sleep disorders

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sleep disorders
Sponsor
HS R&D Regional Programme Register - Department of Health (UK)
Enrollment
66
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 23, 2004
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
HS R&D Regional Programme Register - Department of Health (UK)

Eligibility Criteria

Inclusion Criteria

  • •1\. Children age 2\-5 years
  • •2\. Male or female
  • •3\. Severe learning disability
  • •4\. Severe sleep disorder present \>3 months with the following characteristics
  • •4\.1\. Night waking \>3x/week disturbing parents
  • •4\.2\. Taking \>1 hr to settle child \>3x/week

Exclusion Criteria

  • •Sleep problems thought to be due to physical discomfort

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Development of diagnosis and treatment strategy for breast cancer based on molecular classificatioBreast Cancer and benign breast disease
JPRN-UMIN000038962Hyogo College of Medicine2,100
Recruiting
Not Applicable
Development of diagnostic and treatment strategy for resistant hypertensio
KCT0003300Yonsei University Health System, Severance Hospital780
Completed
Phase 2
Efficacy and feasibility of first-line treatment with risk-adapted dose-adjusted EPOCH-R (DA-EPOCH-R) in patients with Burkitt lymphoma. A phase II clinical trial.Burkitt lymphomahighly aggressive B cell lymphoma10025320
NL-OMON36941Vrije Universiteit Medisch Centrum22
Active, not recruiting
Not Applicable
A trial to investigate treatment with EPOCH-R in patients with Burkitt lymphoma, by adapting the dose to the risk classification of the disease.Burkitt lymphomaMedDRA version: 14.1Level: HLTClassification code 10006596Term: Burkitt's lymphomasSystem Organ Class: 10005329 - Blood and lymphatic system disordersTherapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2012-003141-16-NLVU University Medical Center
Completed
Not Applicable
Development of a comprehensive treatment based on psychosocial approach for support for the individuals with early psychosisPsychotic disorders A nurse working in a Psychiatric hospital
JPRN-UMIN000031268Tohoku University20